Kirkbi Buys Enerparc

Kirkbi buys Enerparc.
Kirkbi buys a majority stake in solar developer Enerparc Inc. Enerparc’s management team keeps minority ownership.
Enerparc develops, engineers, builds and operates distributed utility-scale photovoltaic projects. They support the transition of commercial energy supply to renewable forms of power by connecting large-scale solar photovoltaic systems to the grid.
This deal is an evolution in Kirkbi’s renewable venture strategy. Kirkbi is already a recognized investor in offshore wind farms. The Lego Group is already 100 percent renewable-powered and has solar power on its own property. Lego likes to tell the story, a good one: The original wooden Lego bricks were fine until the firm bought this newfangled plastic injection molding machine in the 1940s.
Thomas Lau Schleicher of Kirkbi said: ‘The significant majority stake in Enerparc gives Kirkbi a unique opportunity to take ownership in a company that has established an operational, commercial, and scalable platform to bring solar power to more Americans. We look forward to working with the Enerparc team and supporting the company’s future growth in US solar power generation, for which the demand remains strong.’
Florent Abadie of Enerparc, Inc., said: ‘In building a solar photovoltaic portfolio capable of powering 20,000 average homes across the US, I am delighted to welcome Kirkbi as a majority shareholder in Enerparc. As we pursue our growth strategy, we stay committed to serving our clients, partners, and suppliers to help North America’s transition to a greener economy.’

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more